Examining Clinical Trial Design for Phase 2 CKD Studies to Provide Confidence in Endpoints, Sample Size & Outcome Predictions
Time: 1:00 pm
day: Day One Track 2 PM
Details:
- Explore strategies for designing Phase 2 trials that are more predictive of Phase 3 success, focusing on proper patient stratification and using surrogate markers effectively to gauge outcomes early on
- Review the challenges of selecting appropriate Phase 2 endpoints and sample sizes, ensuring that trial design is robust enough to provide meaningful data while balancing costs and timeline considerations
- Explore innovations in adaptive trial design that allow for flexible modifications based on interim results, improving the confidence in trial outcomes and lead to more informed decision-making for Phase 3